These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24337404)

  • 41. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
    Kaltenecker D; Themanns M; Mueller KM; Spirk K; Golob-Schwarzl N; Friedbichler K; Kenner L; Haybaeck J; Moriggl R
    Cytokine; 2019 Dec; 124():154573. PubMed ID: 30377054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zinc fingers and homeoboxes 2 is required for diethylnitrosamine-induced liver tumor formation in C57BL/6 mice.
    Jiang J; Turpin C; Qiu GS; Xu M; Lee E; Hinds TD; Peterson ML; Spear BT
    Hepatol Commun; 2022 Dec; 6(12):3550-3562. PubMed ID: 36194180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
    Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
    Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
    Boye A; Kan H; Wu C; Jiang Y; Yang X; He S; Yang Y
    Tumour Biol; 2015 May; 36(5):3643-51. PubMed ID: 25560488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LASS2 inhibits proliferation and induces apoptosis in HepG2 cells by affecting mitochondrial dynamics, the cell cycle and the nuclear factor‑κB pathways.
    Yang Y; Yang X; Li L; Yang G; Ouyang X; Xiang J; Zhang T; Min X
    Oncol Rep; 2019 May; 41(5):3005-3014. PubMed ID: 30896811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Obstruction of TGF-beta1 signal transduction can decrease the process of hepatocellular carcinoma in mice induced by CCl4/ethanol].
    Xu XB; Leng XS; Yang X; He ZP
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1122-5. PubMed ID: 15312519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
    Abderrahmani R; François A; Buard V; Benderitter M; Sabourin JC; Crandall DL; Milliat F
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):942-8. PubMed ID: 19480973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
    Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
    Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [LASS2 interacts with V-ATPase and inhibits cell growth of hepatocellular carcinoma].
    Tang N; Jin J; Deng Y; Ke RH; Shen QJ; Fan SH; Qin WX
    Sheng Li Xue Bao; 2010 Jun; 62(3):196-202. PubMed ID: 20571735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
    Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. iPLA2β-Null Mice Show HCC Protection by an Induction of Cell-Cycle Arrest after Diethylnitrosamine Treatment.
    Andrade A; Poth T; Brobeil A; Merle U; Chamulitrat W
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer research.
    Pok S; Vohra H; Wehbe C; Barn VA; Arfianti E; Dan YY; Farrell GC; Teoh NC
    Exp Cell Res; 2017 Jul; 356(1):48-56. PubMed ID: 28408319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
    Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L
    Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
    Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
    Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
    Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LASS2 regulates hepatocyte steatosis by interacting with NDUFS2/OXPHOS related proteins.
    Yang Y; Yang X; Lin Y; Yang G; Li L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):871-879. PubMed ID: 32279995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.